The Interaction of FK409, a Novel Nitric Oxide Releaser, and Peripherally Administered Morphine During Experimental Inflammation
- 1 February 1998
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 86 (2) , 367-373
- https://doi.org/10.1213/00000539-199802000-00028
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- A New Nitric Oxide (No) Releaser: Spontaneous No Release from Fk409Free Radical Research, 1995
- Effect of topical administration of l‐arginine on formalin‐induced nociception in the mouse: a dual role of peripherally formed NO in pain modulationBritish Journal of Pharmacology, 1994
- Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409European Journal of Pharmacology, 1994
- Nitric Oxide Synthase Inhibitor Blocks Spinal Sensitization Induced by Formalin Injection into the Rat PawAnesthesia & Analgesia, 1993
- l‐Leucyl‐l‐arginine, naltrindole and d‐arginine block antinociception elicited by l‐arginine in mice with carrageenin‐induced hyperalgesiaBritish Journal of Pharmacology, 1992
- Antinociceptive effect of L-arginine on the carrageenin-induced hyperalgesia of the rat: possible involvement of central opioidergic systemsEuropean Journal of Pharmacology, 1992
- Nitric oxide, a novel neuronal messengerNeuron, 1992
- Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathwayEuropean Journal of Pharmacology, 1990
- FK409, a novel vasodilator isolated from the acid-treated fermentation broth of Streptomyces griseosporeus. I. Taxonomy, fermentation, isolation, and physico-chemical and biological characteristics.The Journal of Antibiotics, 1989
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987